Bland Embolization in the Treatment of Hepatic Adenomas: Preliminary Experience

被引：26

作者：

Deodhar, Ajita ^{[1
]}

Brody, Lynn A. ^{[1
]}

Covey, Anne M. ^{[1
]}

Brown, Karen T. ^{[1
]}

Getrajdman, George I. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Sect Intervent Radiol & Image Guided Therapies, New York, NY 10021 USA

来源：

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY | 2011年 / 22卷 / 06期

关键词：

PERCUTANEOUS RADIOFREQUENCY ABLATION; LIVER-CELL ADENOMAS; ARTERIAL EMBOLIZATION; HEPATOCELLULAR-CARCINOMA; CHEMOEMBOLIZATION; MALIGNANCY; MANAGEMENT;

D O I：

10.1016/j.jvir.2011.02.027

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The study presents preliminary, retrospective experience with bland embolization for hepatic adenomas (HAs) with the use of tris-acryl gelatin microspheres. Eight patients underwent bland embolization for biopsy-proven HAs. A biopsy specimen was taken from only one lesion when multiple lesions were present. Seventeen embolizations were performed for abdominal pain, active bleeding, or prophylaxis against bleeding. Five patients underwent multiple procedures. Technical success rate was 100%. Median follow-up was 24 months (range, 10-40 mo). No growth was observed at follow-up in any treated lesion, and many lesions (13 of 16) regressed. Bland embolization may be safely used for treatment of abdominal pain and bleeding from HAs.

引用

页码：795 / 799

页数：5

共 23 条

[1] Management of Unresectable Symptomatic Focal Nodular Hyperplasia with Arterial Embolization [J].

Amesur, Nikhil ;

Hammond, John S. ;

Zajko, Albert B. ;

Geller, David A. ;

Gamblin, T. Clark .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 20 (04) :543-547

[2]

[Anonymous], 2002, Diseases of the Liver and Biliary System

[3] Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation [J].

Atwell, TD ;

Brandhagen, DJ ;

Charboneau, JW ;

Nagorney, DM ;

Callstrom, MR ;

Farrell, MA .

AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (03) :828-831

[4]

Barthelmes Ludger, 2005, HPB (Oxford), V7, P186, DOI 10.1080/13651820510028954

[5]

BOYD PR, 1977, CANCER-AM CANCER SOC, V40, P1765, DOI 10.1002/1097-0142(197710)40:4<1765::AID-CNCR2820400455>3.0.CO

[6]

2-Y

[7] Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy [J].

Brown, DB ;

Cardella, JF ;

Sacks, D ;

Goldberg, SN ;

Gervais, DA ;

Rajan, D ;

Vedantham, S ;

Miller, DL ;

Brountzos, EN ;

Grassi, CJ ;

Towbin, RB .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (02) :225-232

[8] Liver Cell Adenoma: A Multicenter Analysis of Risk Factors for Rupture and Malignancy [J].

Deneve, Jeremiah L. ;

Pawlik, Timothy M. ;

Cunningham, Steve ;

Clary, Bryan ;

Reddy, Srinevas ;

Scoggins, Charles R. ;

Martin, Robert C. G. ;

D'Angelica, Michael ;

Staley, Charles A. ;

Choti, Michael A. ;

Jarnagin, William R. ;

Schulick, Richard D. ;

Kooby, David A. .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (03) :640-648

[9] LIVER-CELL ADENOMAS ASSOCIATED WITH USE OF ORAL-CONTRACEPTIVES [J].

EDMONDSON, HA ;

HENDERSON, B ;

BENTON, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (09) :470-472

[10]

FLOWERS BF, 1990, AM SURGEON, V56, P380

← 1 2 3 →